Gilead Sciences, Inc. (ETR:GIS)
Germany · Delayed Price · Currency is EUR 105.38
-1.82 (-1.70%)
At close: Dec 22, 2025
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of €131.01 billion as of December 22, 2025. Its market cap has increased by 20.87% in one year.
Market Cap
131.01B
Enterprise Value
143.23B
Revenue
24.79B
Ranking
n/a
PE Ratio
18.95
Stock Price
€105.38
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 194.48M to 131.01B, an increase of 67,266.40%. That is a compound annual growth rate of 21.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 131.60B | 18.35% |
| Dec 31, 2024 | 111.19B | 21.76% |
| Dec 29, 2023 | 91.32B | -9.36% |
| Dec 30, 2022 | 100.75B | 25.80% |
| Dec 31, 2021 | 80.09B | 34.14% |
| Dec 31, 2020 | 59.70B | -18.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 51.87B |
| Siemens Healthineers AG | 49.61B |
| Bayer Aktiengesellschaft | 35.25B |
| Fresenius SE & Co. KGaA | 27.20B |
| Sartorius Aktiengesellschaft | 14.73B |
| Fresenius Medical Care AG | 11.50B |
| Fielmann Group AG | 3.62B |
| Carl Zeiss Meditec AG | 3.51B |